Get the Stockscreener App
5.73
4.50%
-0.27
After Hours:
5.76
0.03
+0.52%
Champions Oncology Inc stock is traded at $5.73, with a volume of 9,556.
It is down -4.50% in the last 24 hours and down -12.25% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$6.00
Open:
$5.845
24h Volume:
9,556
Relative Volume:
0.84
Market Cap:
$79.57M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-8.0704
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
-4.34%
1M Performance:
-12.25%
6M Performance:
-16.23%
1Y Performance:
-44.90%
1-Day Range:
$5.73
$5.87
1-Week Range:
$5.73
$6.24
52-Week Range:
$5.592
$10.57
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
5.73 | 83.32M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 - Bluefield Daily Telegraph
CSBR SEC FilingsChampions Oncolo 10-K, 10-Q, 8-K Forms - Stock Titan
Behavioral Patterns of CSBR and Institutional Flows - Stock Traders Daily
IMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FGBI PE Ratio & Valuation, Is FGBI Overvalued - Intellectia AI
SFBC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NOTV Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is the earnings history of CREVCEO Change & Low Drawdown Trading Techniques - mfd.ru
Whale Trades: Will Champions Oncology Inc outperform the market in YEARLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
OKYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
EV Market: Should value investors consider CNVSTrade Signal Summary & Stock Market Timing Techniques - baoquankhu1.vn
Patient Derived Xenografts/PDX Models Market Research and Global Forecast Report 2025-2030 - GlobeNewswire
Insider Sell: Is Yunhong Green CTI Ltd stock forming a cup and handleWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IPO Launch: Is Hovnanian Enterprises Inc likely to announce a buybackRecession Risk & Reliable Breakout Stock Forecasts - baoquankhu1.vn
START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit - Morningstar
Analyst Calls: What are the risks of holding GLOBALFOUNDRIES IncJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
Is Champions Oncology Inc. benefiting from innovation trendsJuly 2025 Drop Watch & Breakout Confirmation Alerts - mfd.ru
Is Champions Oncology Inc. stock supported by strong fundamentals2025 Geopolitical Influence & Technical Pattern Recognition Alerts - mfd.ru
Aug Gainers: Is now the right time to enter Cadre Holdings IncQuarterly Portfolio Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
(CSBR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Trading Recap: How does Fifth Third Bancorp compare to its peersJuly 2025 Chart Watch & Real-Time Volume Triggers - baoquankhu1.vn
Patterns Watch: How does FBRX compare to its peersBear Alert & Accurate Entry/Exit Alerts - baoquankhu1.vn
LCUT PE Ratio & Valuation, Is LCUT Overvalued - Intellectia AI
Is Champions Oncology Inc. stock resilient to inflationQuarterly Trade Summary & High Accuracy Investment Entry Signals - mfd.ru
Optex Systems Q1 Earnings Highlights - Intellectia AI
A activity2025 Price Action Summary & Verified Swing Trading Watchlist - mfd.ru
What are analysts’ price targets for Champions Oncology Inc.July 2025 Drop Watch & Free Growth Oriented Trading Recommendations - mfd.ru
Can FTCI stock attract ESG capital inflows2025 Price Action Summary & Fast Gain Swing Alerts - mfd.ru
How (CSBR) Movements Inform Risk Allocation Models - Stock Traders Daily
Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care – Company Announcement - Financial Times
Dow Update: What is Champions Oncology Incs debt to equity ratio2025 Stock Rankings & Daily Stock Trend Reports - baoquankhu1.vn
Signal Recap: Can Champions Oncology Inc weather a recessionLong Setup & Fast Moving Trade Plans - baoquankhu1.vn
Fund Flows: What are the analyst revisions for PRLBIs SPXC stock a good investment in YEARMarket Risk Analysis & High Win Rate Trade Tips - baoquankhu1.vn
Short Covering: Will Champions Oncology Inc benefit from geopolitical trendsTrade Exit Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Trading Systems Reacting to (CSBR) Volatility - Stock Traders Daily
Champions Oncology (CSBR) Earnings Transcript - AOL.com
Trading Recap: Is Liminatus Pharma Inc forming a breakout patternEarnings Beat & Weekly High Momentum Picks - baoquankhu1.vn
Decliners Report: Is OSIS a strong growth stockJuly 2025 Patterns & Reliable Intraday Trade Alerts - baoquankhu1.vn
What is the implied volatility of Dime Community Bancshares Inc. Preferred SecurityJuly 2025 Short Interest & Safe Entry Momentum Tips - bollywoodhelpline.com
How Champions Oncology Inc. (CSBR) Affects Rotational Strategy Timing - Stock Traders Daily
Is Champions Oncology, Inc.'s (NASDAQ:CSBR) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
NIIT Learning Systems Limited Stock Poised for Technical ComebackDay Trading Setups & Market-Leading Growth Rates - bollywoodhelpline.com
Apollo Micro Systems Limited (540879) Gets Regulatory ApprovalCurrency Fluctuation Impact & Free High Impact Stock Picks - bollywoodhelpline.com
Is Champions Oncology Inc. stock a top momentum play2025 Fundamental Recap & Community Verified Trade Alerts - Улправда
2026 world cup france final rising stars newsVolume Spike & Technical Buy Zone Confirmations - Улправда
How Champions Oncology Inc. stock benefits from tech adoptionMarket Trend Review & Momentum Based Trading Signals - Улправда
2026 world cup spain qualifiers match preview insightsEarnings Recap Report & Weekly High Return Stock Opportunities - ulpravda.ru
Why Horizon Space Acquisition I Corp. Equity Right stock could rally in 2025Buy Signal & AI Driven Stock Reports - Улправда
2026 world cup mexico qualification goalkeepers possession football knockout prediction newsRecession Risk & Risk Controlled Swing Alerts - ulpravda.ru
Is Champions Oncology Inc. stock a top pick in earnings seasonSell Signal & Real-Time Chart Pattern Alerts - ulpravda.ru
Dip Buying: How Pacer Fund Trust Pacer Trendpilot stock reacts to new regulationsJuly 2025 Summary & Daily Market Momentum Tracking - Улправда
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):